Skip to main content

Find Clinical Trials

Home
Conditions
Narcolepsy

Clinical trial condition

Narcolepsy

Explore clinical trials studying Narcolepsy. Study availability and eligibility vary by location and protocol.

116 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Narcolepsy trial results

Completed

A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

NCT01681121

Conditions: Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations: Sleep Disorders Center of Alabama Birmingham, Alabama, United States

Pulmonary Associates Phoenix, Arizona, United States

Stanford Sleep Medicine Center Redwood City, California, United States

Pacific Research Network San Diego, California, United States

View all 28 locations

View Trial Details

Completed

Xyrem and Brain Dopamine in Narcolepsy

NCT02637076

Conditions: Disorders of Excessive Somnolence, Dyssomnias, Healthy Controls, +6 more
Locations: Centre for Addiction and Mental Health (CAMH) Toronto, Ontario, Canada

View Trial Details

Completed

Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy

NCT02806908

Conditions: Disorders of Excessive Somnolence, Dyssomnias, Excessive Sleepiness, +5 more
Locations: Maastricht University Maastricht, Limburg, Netherlands

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy

NCT03748979

Conditions: Disorders of Excessive Somnolence, Dyssomnias, Healthy Participants, +5 more
Locations: Sumida Hospital Sumida-ku, Tokyo, Japan

Hakata Clinic Fukuoka, Japan

PS Clinic Fukuoka, Japan

View Trial Details

Completed

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

NCT03030599

Conditions: Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +5 more
Locations: SDS Clinical Trials, Inc. Orange, California, United States

Stanford Health Services Stanford, California, United States

Colorado Sleep Institute Boulder, Colorado, United States

Pulmonary Disease Specialists Kissimmee, Florida, United States

View all 25 locations

View Trial Details

Completed

Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients

NCT02821715

Conditions: Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations: RespiSom Erpent, Belgium

CHU Pellegrin Bordeaux, France

CHU Dijon Bourgogne Dijon, France

Hôpital Raymond Poincaré Garches, France

View Trial Details

Completed

Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)

NCT04232644

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations: BioPharma Services Inc. Toronto, Ontario, Canada

View Trial Details

Completed

Psychosocial Adjunctive Treatment for Hypersomnia (PATH)

NCT03904238

Conditions: Disorders of Excessive Somnolence, Dyssomnias, Idiopathic Hypersomnia, +5 more
Locations: Center for Circadian and Sleep Medicine, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"

NCT02348593

Conditions: Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations: Sleep Disorders Center of Alabama Birmingham, Alabama, United States

Pulmonary Associates Glendale, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Preferred Research Partners Little Rock, Arkansas, United States

View all 60 locations

View Trial Details

Completed

"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"

NCT02348632

Conditions: Apnea, Disorders of Excessive Somnolence, Dyssomnias, +10 more
Locations: Sleep Disorders Center of Alabama Birmingham, Alabama, United States

Pulmonary Associates Glendale, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Preferred Research Partners Little Rock, Arkansas, United States

View all 80 locations

View Trial Details